Bionano Genomics, Inc. (BNGO) Earnings History
Annual and quarterly earnings data from 2016 to 2025
Loading earnings history...
BNGO EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
BNGO Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 49.4% | -116.9% | -92.6% |
| 2024 | 1.2% | -337.9% | -364.0% |
| 2023 | 26.5% | -596.0% | -643.7% |
| 2022 | 21.4% | -473.7% | -476.9% |
| 2021 | 21.5% | -428.8% | -402.8% |
Download Data
Export BNGO earnings history in CSV or JSON format
Free sign-in required to download data
Bionano Genomics, Inc. (BNGO) Earnings Overview
As of May 8, 2026, Bionano Genomics, Inc. (BNGO) reported trailing twelve-month net income of -$26M, reflecting +94.5% year-over-year growth. The company earned $-4.85 per diluted share over the past four quarters, with a net profit margin of -92.6%.
Looking at the long-term picture, BNGO's historical earnings data spans multiple years. The company achieved its highest annual net income of -$18M in fiscal 2018.
Bionano Genomics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PACB (-$546M net income, -341.5% margin), CDNA (-$8M net income, -5.6% margin), NTRA (-$208M net income, -9.0% margin), BNGO has outperformed on profitability metrics. Compare BNGO vs PACB →
BNGO Earnings vs Peers
Earnings metrics vs comparable public companies
BNGO Historical Earnings Data (2016–2025)
10 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$26M | +76.4% | -$33M | $-4.85 | -92.6% | -116.9% |
| 2024 | -$112M | +51.8% | -$104M | $-88.13 | -364.0% | -337.9% |
| 2023 | -$232M | -75.3% | -$215M | $-408.60 | -643.7% | -596.0% |
| 2022 | -$133M | -83.1% | -$132M | $-267.71 | -476.9% | -473.7% |
| 2021 | -$72M | -76.2% | -$77M | $-157.02 | -402.8% | -428.8% |
| 2020 | -$41M | -37.9% | -$39M | $-14194.80 | -483.4% | -453.4% |
| 2019 | -$30M | -61.2% | -$26M | $-71662.20 | -294.3% | -255.4% |
| 2018 | -$18M | +20.8% | -$20M | $-94089.60 | -154.1% | -170.1% |
| 2017 | -$23M | -24.0% | -$23M | $0.00 | -245.8% | -244.3% |
| 2016 | -$19M | - | -$21M | $0.00 | -277.5% | -311.6% |
See BNGO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BNGO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BNGO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBNGO — Frequently Asked Questions
Quick answers to the most common questions about buying BNGO stock.
Is BNGO growing earnings?
BNGO EPS is $-4.85, with earnings growth accelerating to +94.5%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-26M.
What are BNGO's profit margins?
Bionano Genomics, Inc. net margin is -92.6%, with operating margin at -116.9%. Below-average margins reflect competitive or cost pressures.
How consistent are BNGO's earnings?
BNGO earnings data spans 2016-2025. The accelerating earnings trend is +94.5% YoY. Historical data enables comparison across business cycles.